Active	Status	Sponsor type	Region	Phase	Filter
1 Active 2 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
GRAd-COV2 / ReiThera, Leukocare, Univercells
COVITAR, NCT04791423 / 2020-005915-39: Study of GRAd-COV2 for the Prevention of COVID-19 in Adults	Completed	2/3	10300	Europe	GRAd-COV2, Placebo	ReiThera Srl, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani	Covid19	06/21	05/22

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
GRAd-COV2 / ReiThera, Leukocare, Univercells
COVITAR, NCT04791423 / 2020-005915-39: Study of GRAd-COV2 for the Prevention of COVID-19 in Adults	Completed	2/3	10300	Europe	GRAd-COV2, Placebo	ReiThera Srl, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani	Covid19	06/21	05/22